drugset / Trial / NCT01193660

Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy

NCT01193660

Completed 105 enrolled Sung Kwang Medical Foundation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized control study is aimed to determine efficacy of umbilical cord blood and erythropoietin combination therapy for children with cerebral palsy.

Timeline

Start
2010-05
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 3e+07 cells/kg Intravenous
Subject epoetin alfa Protein / enzyme biologic 250 iu/kg Intravenous
Subject epoetin alfa Protein / enzyme biologic 500 iu/kg Intravenous

Indications